These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7007069)

  • 21. Role of antioxidant defence, renal toxicity markers and inflammatory cascade in disease progression of acute pyelonephritis in experimental rat model.
    Vysakh A; Raji NR; Suma D; Jayesh K; Jyothis M; Latha MS
    Microb Pathog; 2017 Aug; 109():189-194. PubMed ID: 28578087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyelonephritis: the role of cell-mediated immunity defined in a congenitally athymic rat.
    Miller T
    Kidney Int; 1984 Dec; 26(6):816-22. PubMed ID: 6398381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site of bacterial colonization in acute pyelonephritis induced in rats by Escherichia coli.
    Shimamura T; Cotton J; Wang JC
    Exp Mol Pathol; 1978 Oct; 29(2):253-9. PubMed ID: 357175
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis.
    Sullivan MJ; Harvey RA; Shimamura T
    Yale J Biol Med; 1977; 50(3):267-73. PubMed ID: 329591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteremia in the pathogenesis of retrograde E. coli pyelonephritis in the rat.
    Fierer J; Talner L; Braude AI
    Am J Pathol; 1971 Aug; 64(2):443-56. PubMed ID: 4946881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.
    Kaboré AF; Simard M; Bergeron MG
    J Infect Dis; 1999 May; 179(5):1162-72. PubMed ID: 10191219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the antibacterial effect of nalidixic acid in two experimental models of Escherichia coli pyelonephritis.
    Prát V; Konícková L; Hatala M; Urbanová D
    Br J Exp Pathol; 1968 Feb; 49(1):60-7. PubMed ID: 4867859
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.
    Brooks SJ; Lyons JM; Braude AI
    J Infect Dis; 1977 Nov; 136(5):633-9. PubMed ID: 335001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental pyelonephritis--a histopathological study of blood borne and ascending patterns of infection.
    Prakash C; Gupta RR
    J Assoc Physicians India; 1975 Jul; 23(7):409-13. PubMed ID: 1104567
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux.
    Roberts JA; Suarez GM; Kaack B; Kallenius G; Svenson SB
    J Urol; 1985 Jun; 133(6):1068-75. PubMed ID: 2860250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental pyelonephritis. Route of infection, course and immunological aspects.
    Tuan H; Hagemann I; Briedigkeit H; Dutz W
    Int Urol Nephrol; 1972; 4(3):285-95. PubMed ID: 4592133
    [No Abstract]   [Full Text] [Related]  

  • 32. [Iatrogenic pyelonephritis from the morphological viewpoint. I. Comments on morphology and pathogenesis of pyelonephritis].
    Ditscherlein G
    Z Urol Nephrol; 1971 Oct; 64(10):729-36. PubMed ID: 4945982
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis.
    Winberg J; Bollgren I; Källenius G; Möllby R; Svenson SB
    Pediatr Clin North Am; 1982 Aug; 29(4):801-14. PubMed ID: 6125926
    [No Abstract]   [Full Text] [Related]  

  • 34. Strain-dependent difference in susceptibility of mice to experimental ascending pyelonephritis.
    Guze PA; Kalmanson GM; Ishida K; Guze LB
    J Infect Dis; 1987 Sep; 156(3):523-5. PubMed ID: 3112242
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental studies on the etiology and pathogenesis of pyelonephritis].
    Mohr HJ
    Beitr Pathol Anat; 1969; 138(4):357-76. PubMed ID: 4239799
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for obstructive etiology in intravenous bacterial pyelonephritis.
    Fry TL; Fried FA; Goven BA
    J Surg Res; 1975 Mar; 18(3):277-84. PubMed ID: 1094197
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.
    Goluszko P; Moseley SL; Truong LD; Kaul A; Williford JR; Selvarangan R; Nowicki S; Nowicki B
    J Clin Invest; 1997 Apr; 99(7):1662-72. PubMed ID: 9120010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal cytokine responses in acute Escherichia coli pyelonephritis in IL-6-deficient mice.
    Khalil A; Tullus K; Bartfai T; Bakhiet M; Jaremko G; Brauner A
    Clin Exp Immunol; 2000 Nov; 122(2):200-6. PubMed ID: 11091275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escherichia coli-specific T lymphocytes in experimental pyelonephritis.
    Kurnick JT; McCluskey RT; Bhan AK; Wright KA; Wilkinson R; Rubin RH
    J Immunol; 1988 Nov; 141(9):3220-6. PubMed ID: 2459249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental pyelonephritis. XVII. Enhancement of pyelonephritis by water diuresis following direct inoculation of E. coli in the renal medulla of the rat.
    Danzig MD; Freedman LR
    Yale J Biol Med; 1972 Feb; 45(1):1-11. PubMed ID: 4552531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.